Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary Stenosis

June 22, 2018 updated by: FERNANDA PRATA MARTINS, Hospital Israelita Albert Einstein

Self-expandable Metalic Stent Versus Multiple Plastic Stents in Post OLT Biliary Stenosis: Prospective, Randomized, Controlled Trial.

Biliary complications are one of the most common problems after orthotopic liver transplantation (OLT),occurring in up to 24% of patients.

Anastomotic strictures have been endoscopically managed with plastic stents placement. Recently, partially and fully covered metal stents have been alternatively used to treat refractory benign biliary stenosis. The investigators purpose is to compare efficacy and safety of metallic stents versus multiple plastic stents in the endoscopic management of post transplant biliary complications.

Study Overview

Detailed Description

Patients with biliary stricture after OLT will be randomly assigned following simple randomization to temporary placement of fully covered self-expandable metal stent (SEMS) or multiple plastic stents placement were randomized according to a computer generated randomization sequence and allocated in a 1:1 ratio to one of two treatment groups.

Final success will be defined as clinical resolution of the stricture without the need to repeat endoscopic, percutaneous or surgical treatment.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • SP
      • Sao Paulo, SP, Brazil, 05652900
        • Hospital Israelita Albert Einstein

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • post-OLT biliary anastomotic stenosis (at least 1 month post-operative)
  • jaundice, cholestasis and/or biliary tree dilation on US

Exclusion Criteria:

  • biliary fistulae
  • non-anastomotic stricture
  • combine anastomotic and non-anastomotic stricture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Multiple plastic stents
Multiple plastic stents placement after sphincterotomy and stricutre dilation. ERCP repeated every 3 - 4 months during 1-year
Comparison of self-expandable metalic stent versus multiple plastic stents in post OLT biliary stenosis.
Other Names:
  • Boston Scientific
  • Wilson Cook
  • Olympus
EXPERIMENTAL: Self-expandable metalic stent
Self-expandable metalic stent after sphincterotomy. Stent removal scheduled for 6 months
Comparison of self-expandable metalic stent versus multiple plastic stents in post OLT biliary stenosis.
Other Names:
  • Wallflex, Boston Scientific

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post OLT biliary stricture resolution after stent removal
Time Frame: Up to 1 year
Post OLT biliary stricture resolution will be evaluated during endoscopic stents removal up to 1 year after initial stents placement.
Up to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained improvement after endoscopic treatment
Time Frame: 1 year after biliary stenosis resolution
Stricture resolution persistent after 1 year
1 year after biliary stenosis resolution
Occurence and severity of complications related to the endoscopic procedures
Time Frame: Up to 1 month
Occurence and severity of complications after therapeutic ERCP will be evaluated and recorded up to 1 month after endoscopic procedures.
Up to 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: FERNANDA P MARTINS, MD, Hospital Israelita Albert Einstein
  • Study Chair: ANGELO P FERRARI, MD, Hospital Israelita Albert Einstein

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (ACTUAL)

February 1, 2015

Study Completion (ACTUAL)

February 1, 2016

Study Registration Dates

First Submitted

June 21, 2010

First Submitted That Met QC Criteria

June 21, 2010

First Posted (ESTIMATE)

June 22, 2010

Study Record Updates

Last Update Posted (ACTUAL)

June 26, 2018

Last Update Submitted That Met QC Criteria

June 22, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biliary Stricture

Clinical Trials on Multiple plastic stents

3
Subscribe